Robert M. Savel, II

Mr. Savel has served as Otonomy’s chief technical officer since January 2014. From 2011 to December 2013, Mr. Savel served as general manager and senior vice president of operations for Optimer Pharmaceuticals, Inc., a biopharmaceutical company. From 2010 to 2011, Mr. Savel served as senior vice president and chief technical officer for Inspire Pharmaceuticals, Inc., an ophthalmic pharmaceutical company. From 2008 to 2010, Mr. Savel served as president of Savel Enterprises LLC, a management consulting firm. From 2007 to 2008, Mr. Savel served as the senior vice president of Technical Operations for PDL BioPharma, an antibody manufacturer.

Earlier in his career, he held leadership operating positions with Johnson & Johnson, a medical devices, pharmaceutical and consumer packaged goods manufacturer, which included the position of vice president, Quality and Compliance. Mr. Savel received his bachelor’s degree in mechanical engineering from Virginia Polytechnic Institute and State University.

Robert M. Savel, II is the Chief Technical Officer at Otonomy, based in United States, North America. With a background in Biotechnology, Robert M. Savel, II has a rich history of leadership and innovation.Robert M. Savel, II studied Bachelors Mechanical Engineering at Virginia Tech. Explore their detailed professional journey, key connections, and contributions to the industry on our platform.